Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer

BACKGROUND: Programmed cell death 4 (Pdcd4) is a novel tumour suppressor and originally identified as a neoplastic transformation inhibitor. The aim of this study was to investigate the expression, prognostic significance and potential function of Pdcd4 in ovarian cancer. RESULTS: The expression of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wei, Na, Liu, Stephanie S, Leung, Thomas HY, Tam, Kar F, Liao, Xiao Y, Cheung, Annie NY, Chan, Karen KL, Ngan, Hextan YS
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2009
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2745358/
https://ncbi.nlm.nih.gov/pubmed/19728867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-8-70
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars